Study guide

8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters

Key Takeaways Explain This Topic AI

Peripheral pulse pressure amplification causes radial and dorsalis pedis arterial lines to exhibit higher systolic blood pressure, lower diastolic blood pressure, and wider pulse pressure than central aortic tracings, while mean arterial pressure (MAP) remains essentially unchanged.

Underdamped arterial line systems (natural frequency too close to pulse frequency) overestimate SBP and underestimate DBP, whereas overdamped systems underestimate SBP and overestimate DBP; MAP is mathematically preserved and reliable in both.

The normal CVP waveform consists of 3 positive waves (a = atrial contraction, c = tricuspid bulging, v = venous filling) and 2 descents (x = atrial relaxation, y = tricuspid opening); cannon a waves indicate AV dissociation, and giant v waves signify tricuspid regurgitation.

Pulmonary artery catheter waveform transition progresses from RA (2-6 mmHg) to RV (25/0-5 mmHg) to PA (25/10 mmHg) to PAOP (6-12 mmHg); PA catheter tips must reside in West Zone 3 (Pa > Pv > PA) to accurately reflect left atrial pressure.

Thermodilution cardiac output is inversely proportional to the area under the temperature-time curve; severe tricuspid regurgitation causes recirculation and artificially enlarges the area, leading to falsely low calculated cardiac output.

Last updated: August 2026

8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters

Invasive hemodynamic monitoring provides beat-to-beat cardiovascular assessment during major surgical interventions, shock states, and complex cardiac procedures. Mastery of waveform analysis, physical damping principles, and intracardiac pressure dynamics allows the CRNA to optimize preload, afterload, inotropy, and tissue perfusion while avoiding catastrophic interpretation errors.

1. Arterial Catheterization: Vascular Sites & Allen Test

Continuous direct arterial pressure monitoring is indicated for patients with severe hemodynamic instability, planned induced hypotension, severe cardiopulmonary disease, major vascular/cardiac surgery, or frequent arterial blood gas requirements. +-------------------------------------------------------------------------+

  • | ARTERIAL CANNULATION SITES |
  • +------------------+------------------------------------------------------+
  • | Arterial Site | Clinical Characteristics & Anesthetic Considerations |
  • +------------------+------------------------------------------------------+
  • | **Radial** | • Most common site; superficial and easily accessible|
  • | | • Dual palmar arch collateral supply via ulnar artery|
  • | **Ulnar** | • Principal blood supplier to the deep palmar arch |
  • | | • Cannulation avoided if ipsilateral radial failed |
  • | **Brachial** | • End artery with no functional collateral network |
  • | | • Risk of median nerve compression & forearm ischemia|
  • | **Femoral** | • Large bore; reliable during profound shock/arrest |
  • | | • Risks: Retroperitoneal hemorrhage, pseudoaneurysm |
  • | **Axillary** | • Left axillary preferred (reduces embolic stroke) |
  • | | • Proximity to neurovascular bundle (brachial plexus)|
  • | **Dorsalis | • Distal peripheral site; exhibits pronounced pulse |
  • | Pedis / PT** | pressure amplification (highest SBP, lowest DBP) |
  • +------------------+------------------------------------------------------+
  • The Modified Allen Test

Purpose: Assesses the patency and adequacy of collateral arterial blood flow to the hand via the ulnar artery and palmar arch prior to radial artery cannulation.

Procedure: The clinician simultaneously occludes both the radial and ulnar arteries while the patient clenches their fist to exsanguinate the hand. With the hand open (avoiding hyperextension), the clinician releases pressure on the ulnar artery only while maintaining firm compression on the radial artery.

Interpretation:

Normal / Adequate Collateral Flow: Hand reperfuses (turns pink) within < 5 − 10 seconds <5 - 10 \text{ seconds} < 5 − 10 seconds .

Equivocal / Borderline: Reperfusion takes 10 − 15 seconds 10 - 15 \text{ seconds} 10 − 15 seconds .

Abnormal / Compromised Collateral Flow: Reperfusion requires > 15 seconds >15 \text{ seconds} > 15 seconds (cannulation of that radial artery is contraindicated due to risk of digital ischemic necrosis).

2. Arterial Waveform Morphology & Peripheral Pulse Pressure Amplification [ARTERIAL PRESSURE WAVEFORM MORPHOLOGY]

  • Pressure (mmHg)
  • 140 |
  • | Peak Systolic Pressure (SBP)
  • 120 | /\
  • | / \
  • 100 | Systolic / \ Dicrotic Notch (Aortic Valve Closure)
  • | Upstroke / \ /
  • 80 | (Anacrotic) \/\_ Diastolic Runoff
  • | | \_
  • 60 | | \_ End-Diastolic Pressure (DBP)
  • +----------------------+-------+-------------------> Time
  • Mechanical Mechanical
  • Systole Diastole
  • Waveform Components

Anacrotic Limb (Systolic Upstroke): Steep initial upstroke representing ventricular ejection velocity and myocardial contractility ( d P / d t dP/dt d P / d t ).

Systolic Peak (SBP): Peak pressure generated during left ventricular ejection.

Dicrotic Limb & Dicrotic Notch (Incisura): The downward deflection interrupted by a notch created by closure of the aortic valve , marking the precise transition from mechanical systole to mechanical diastole.

Diastolic Runoff: Decline in arterial pressure governed by peripheral vascular resistance (SVR) and arterial compliance.

End-Diastolic Pressure (DBP): Trough pressure prior to the next ventricular contraction.

Peripheral Pulse Pressure Amplification

As the arterial pressure pulse wave travels distally from the central ascending aorta toward peripheral muscular arteries (e.g., radial, femoral, dorsalis pedis), it encounters decreasing arterial compliance (stiffer vessel walls) and reflective pressure waves bouncing back from arteriolar branch points. +-------------------------------------------------------------------------+

  • | CENTRAL AORTIC vs PERIPHERAL RADIAL WAVEFORM |
  • +------------------------------------+------------------------------------+
  • | Central Aortic Pressure Waveform | Peripheral Radial Pressure Waveform|
  • +------------------------------------+------------------------------------+
  • | • Lower Systolic Pressure (SBP) | • Higher Systolic Pressure (SBP) |
  • | • Higher Diastolic Pressure (DBP) | • Lower Diastolic Pressure (DBP) |
  • | • Narrower Pulse Pressure (PP) | • Wider Pulse Pressure (PP) |
  • | • Sharp, early Dicrotic Notch | • Delayed, slurred Dicrotic Notch |
  • | • MAP is CONSTANT (or drops ~1-2) | • MAP is CONSTANT (mathematical) |
  • +------------------------------------+------------------------------------+

NCE Clinical Principle — MAP Consistency: Although peripheral SBP is 10 − 20 mmHg 10 - 20 \text{ mmHg} 10 − 20 mmHg higher and peripheral DBP is 5 − 10 mmHg 5 - 10 \text{ mmHg} 5 − 10 mmHg lower than central aortic readings due to reflection wave summation, Mean Arterial Pressure (MAP) remains essentially unchanged across the arterial tree (with only a minuscule 1 − 2 mmHg 1 - 2 \text{ mmHg} 1 − 2 mmHg viscous drop). Thus, MAP is the true physiologic perfusion pressure.

3. Dynamic Transducer Response: Natural Frequency & Damping

An invasive pressure monitoring system consists of an intravascular catheter, fluid-filled non-compliant pressure tubing, continuous flush device ( 3 mL/hr 3 \text{ mL/hr} 3 mL/hr heparinized or plain saline at 300 mmHg 300 \text{ mmHg} 300 mmHg bag pressure), and an electromechanical strain-gauge transducer. +-------------------------------------------------------------------------+

  • | UNDERDAMPED vs OVERDAMPED ARTIFACTS |
  • +-------------------+----------------------------+------------------------+
  • | Parameter | Underdamped (Resonant/Ring)| Overdamped (Blunted) |
  • +-------------------+----------------------------+------------------------+
  • | **Systolic (SBP)**| **Falsely ELEVATED** | **Falsely DECREASED** |
  • | **Diastolic(DBP)**| **Falsely DECREASED** | **Falsely ELEVATED** |
  • | **Pulse Pressure**| **Falsely WIDENED** | **Falsely NARROWED** |
  • | **Mean (MAP)** | **ACCURATE / PRESERVED** | **ACCURATE / PRESERVED**|
  • | **Physical Cause**| • Long tubing, stopcocks, | • Air bubbles in line |
  • | | stiff non-compliant line | • Clots / fibrin sheath|
  • | | • Low natural frequency | • Compliant soft tubing|
  • | **Flush Test** | • >3 oscillations before | • <1 oscillation / no |
  • | **Waveform** | returning to baseline | ringing (slurred) |
  • +-------------------+----------------------------+------------------------+
  • Physical Principles

Natural Frequency ( f n f_n f n ​ ): The frequency at which the transducer system freely oscillates when perturbed. To prevent distortion, the system's natural frequency must be at least 5 to 10 times higher than the fundamental cardiac frequency (ideally > 25 − 30 Hz >25 - 30 \text{ Hz} > 25 − 30 Hz ).

Damping Coefficient ( ζ \zeta ζ ): The measure of friction resisting fluid oscillation in the tubing (optimal damping coefficient is 0.64 − 0.70 0.64 - 0.70 0.64 − 0.70 ).

Square-Wave Flush Test: Activating the high-pressure flush valve generates a square wave. The number of baseline oscillations ("rings") following valve release determines damping status:

Optimally Damped: 1 to 2 oscillations before returning to baseline.

Underdamped: Multiple rapid, sharp oscillations ( > 3 >3 > 3 rings) with overshooting systolic spikes.

Overdamped: Sluggish baseline return with zero oscillations and complete loss of the dicrotic notch.

Transducer Leveling & Hydrostatic Artifacts

Reference Landmark: Transducers are leveled to the phlebostatic axis (4th intercostal space at the mid-axillary line, corresponding to the right atrium).

Head-Up / Sitting Position (Craniotomy): Transducer must be zeroed and leveled at the External Auditory Meatus (Circle of Willis) to accurately assess Cerebral Perfusion Pressure ( C P P = M A P b r a i n − I C P CPP = MAP_{brain} - ICP CPP = M A P b r ain ​ − I CP ).

Hydrostatic Conversion Factor:

1.0 cm H 2 O = 0.74 mmHg 1.0 \text{ cm H}_2\text{O} = 0.74 \text{ mmHg} 1.0 cm H 2 ​ O = 0.74 mmHg

1.0 inch = 2.54 cm ≈ 1.86 − 2.0 mmHg 1.0 \text{ inch} = 2.54 \text{ cm} \approx 1.86 - 2.0 \text{ mmHg} 1.0 inch = 2.54 cm ≈ 1.86 − 2.0 mmHg

Transducer placed BELOW the patient: Falsely ELEVATES displayed blood pressure.

Transducer placed ABOVE the patient: Falsely LOWERS displayed blood pressure.

4. Central Venous Pressure (CVP): Morphology & Kinetics

Central Venous Pressure measures hydrostatic filling pressure in the right atrium and vena cava, clinically approximating right ventricular preload (normal CVP: 2 − 6 mmHg 2 - 6 \text{ mmHg} 2 − 6 mmHg or 3 − 8 cmH 2 O 3 - 8 \text{ cmH}_2\text{O} 3 − 8 cmH 2 ​ O ). [CENTRAL VENOUS PRESSURE WAVEFORM]

  • Pressure (mmHg)
  • 10 |
  • | a
  • 8 | /\ v
  • | / \ c /\
  • 6 | / \/\ / \
  • | / x \/ \ y
  • 4 +---+----------+-----+-------> Time (ECG Correlation)
  • P-Wave QRS T-Wave
  • Normal CVP Waveform Components & Cardiac Timing

Wave / Descent Mechanical Cardiac Event Electrocardiographic Timing

a wave Right Atrial contraction (end-diastole, ejects atrial blood into RV) Immediately follows the P wave on ECG

c wave Isovolumetric RV contraction ; tricuspid valve bulges into right atrium Follows the R wave / QRS complex

x descent Atrial relaxation and downward descent of tricuspid valve during RV ejection Mid-systole (between QRS and T wave)

  • v wave Venous filling of RA against closed tricuspid valve during late systole Synchronous with end of T wave
  • y descent Passive tricuspid opening and rapid early diastolic emptying into RV Early diastole (follows T wave)

5. Pathologic CVP Waveforms & NCE Board Recognition +-------------------------------------------------------------------------+

  • | PATHOLOGIC CVP WAVEFORM PATTERNS |
  • +---------------------+---------------------------------------------------+
  • | Waveform Pathology | Clinical Etiology & Diagnostic Features |
  • +---------------------+---------------------------------------------------+
  • | **Cannon a waves** | • Atrium contracts against a CLOSED tricuspid |
  • | | • Third-Degree (Complete) AV Block, Junctional |
  • | | rhythm, Ventricular Pacing, PVCs, severe TS |
  • | **Absent a waves** | • Loss of coordinated atrial mechanical systole |
  • | | • Atrial Fibrillation / Sinoatrial Arrest |
  • | **Giant v waves** | • Retrograde systolic jet from RV into RA |
  • | **(Fusion Wave)** | • Severe Tricuspid Regurgitation, noncompliant RA |
  • | **Kussmaul's Sign** | • Paradoxical RISE in CVP during spontaneous |
  • | | inspiration; Constrictive Pericarditis / RV MI |
  • | **Tamponade Wave** | • Prominent x descent, blunted/absent y descent |
  • +---------------------+---------------------------------------------------+

NCE Board Distinction — Tamponade vs. Constrictive Pericarditis:

Cardiac Tamponade: Elevated CVP with prominent x x x descent and attenuated/absent y y y descent (high intrapericardial pressure prevents early passive diastolic filling when tricuspid opens).

Constrictive Pericarditis: Elevated CVP with sharp x x x descent and steep, deep y y y descent (creating an "M" or "W" waveform pattern and positive Kussmaul's sign).

6. Pulmonary Artery Catheterization: Waveforms & Hemodynamics

A flow-directed Pulmonary Artery Catheter (PAC / Swan-Ganz) is advanced through the right internal jugular vein into the pulmonary circulation to measure intracardiac pressures, calculate vascular resistances, and determine cardiac output. +---------------------------------------------------------------------------------------+

  • | PULMONARY ARTERY CATHETER INSERTION PROGRESSION |
  • +--------------------+---------------------+--------------------+-----------------------+
  • | Chamber / Vessel | Distance from Rt IJ | Normal Pressure | Waveform Features |
  • +--------------------+---------------------+--------------------+-----------------------+
  • | **Right Atrium** | $20 - 25 \text{ cm}$| $2 - 6 \text{ mmHg}$| Low-pressure a, c, v |
  • | **Right Ventricle**| $30 - 35 \text{ cm}$| $25 / 0 - 5 \text{ mmHg}$| Tall systolic spike, |
  • | | | | diastolic near zero |
  • | **Pulmonary Artery**| $40 - 45 \text{ cm}$| $25 / 10 \text{ mmHg}$| Dicrotic notch present|
  • | | | | diastolic rises to 10 |
  • | **PAOP (Wedge)** | $45 - 55 \text{ cm}$| $6 - 12 \text{ mmHg}$| Low-pressure LA wave |

+--------------------+---------------------+--------------------+-----------------------+ RA (2-6) RV (25/0-5) PA (25/10) PAOP (6-12)

  • /\ /\ /\ /\ /\ /\ /\ /\
  • / \/ \ / \ / \ / \/\_/ \/\_ / \/ \
  • +--------+ +----+ +----+ +------------+ +--------+
  • (Diastolic ~0) (Diastolic ~10
  • w/ Dicrotic Notch)
  • West Zone 3 Catheter Positioning Requirement

For the pulmonary artery occlusion pressure (PAOP) to accurately reflect left atrial pressure (LAP) and left ventricular end-diastolic pressure (LVEDP), the PAC tip must be positioned in West Zone 3 of the lung ( P a > P v > P A P_a > P_v > P_A P a ​ > P v ​ > P A ​ ) .

In West Zone 3, continuous, uninterrupted columns of blood connect the catheter tip directly to the left atrium through patent pulmonary veins.

If the catheter is positioned in Zone 1 or Zone 2 ( P A > P v P_A > P_v P A ​ > P v ​ ), inflating the balloon causes alveolar pressure ( P A P_A P A ​ ) to compress capillaries, causing the transducer to measure alveolar airway pressure rather than left heart filling pressure.

  • 7. Thermodilution Cardiac Output & Mixed Venous Saturation ( S v O 2 SvO_2 S v O 2 ​ )
  • The Stewart-Hamilton Equation

Cardiac output is measured via the thermodilution technique by injecting a known volume ( 5 − 10 mL 5 - 10 \text{ mL} 5 − 10 mL ) of cold or room-temperature saline through the proximal RA port and recording temperature change over time at the distal thermistor tip in the pulmonary artery: C O = V i ⋅ ( T b − T i ) ⋅ K 1 ⋅ K 2 ∫ 0 ∞ Δ T b ( t ) d t CO = \frac{V_i \cdot (T_b - T_i) \cdot K_1 \cdot K_2}{\int_0^\infty \Delta T_b(t) \, dt} CO = ∫ 0 ∞ ​ Δ T b ​ ( t ) d t V i ​ ⋅ ( T b ​ − T i ​ ) ⋅ K 1 ​ ⋅ K 2 ​ ​

Area Under the Curve (AUC): Cardiac output is inversely proportional to the area under the thermodilution temperature-time curve:

High Cardiac Output: Rapid transit of blood → \to → rapid washout of cold bolus → \to → small AUC .

Low Cardiac Output: Slow transit of blood → \to → delayed clearance of cold bolus → \to → large, broad AUC . +-------------------------------------------------------------------------+

  • | THERMODILUTION INACCURACY SCENARIOS |
  • +------------------------------------+------------------------------------+
  • | Error / Pathologic Condition | Cardiac Output Calculation Effect |
  • +------------------------------------+------------------------------------+
  • | **Severe Tricuspid Regurgitation** | • Falsely UNDERESTIMATES CO |
  • | | • Cold injectate regurgitates back |
  • | | and forth, prolonging washout |
  • | | and artificially enlarging AUC |
  • | **Injectate Volume LESS than set** | • Falsely OVERESTIMATES CO |
  • | | • Produces artificially small AUC |
  • | **Injectate Volume GREATER set** | • Falsely UNDERESTIMATES CO |
  • | **Intracardiac Left-to-Right Shunt**| • Invalids thermodilution method |
  • +------------------------------------+------------------------------------+
  • Mixed Venous Oxygen Saturation ( S v O 2 SvO_2 S v O 2 ​ )

Mixed venous blood is sampled from the distal pulmonary artery port of a PAC (normal S v O 2 SvO_2 S v O 2 ​ : 65 − 75 % 65 - 75\% 65 − 75% , P v O 2 ≈ 40 mmHg PvO_2 \approx 40 \text{ mmHg} P v O 2 ​ ≈ 40 mmHg ). Central venous oxygen saturation ( S c v O 2 ScvO_2 S c v O 2 ​ ) drawn from an internal jugular CVP line is normally 70 − 80 % 70 - 80\% 70 − 80% (approximately 3 − 5 % 3 - 5\% 3 − 5% higher than S v O 2 SvO_2 S v O 2 ​ ). S v O 2 = S a O 2 − V O 2 C O ⋅ 1.34 ⋅ [ H b ] ⋅ 10 SvO_2 = SaO_2 - \frac{VO_2}{CO \cdot 1.34 \cdot [Hb] \cdot 10} S v O 2 ​ = S a O 2 ​ − CO ⋅ 1.34 ⋅ [ H b ] ⋅ 10 V O 2 ​ ​ +-------------------------------------------------------------------------+

  • | SvO₂ CLINICAL ALTERATIONS |
  • +------------------------------------+------------------------------------+
  • | Decreased SvO₂ (< 65%) | Increased SvO₂ (> 75-80%) |
  • | (Increased extraction / low supply)| (Decreased extraction / excess sup)|
  • +------------------------------------+------------------------------------+
  • | • Decreased Cardiac Output (shock) | • Severe Sepsis / Endotoxemia |
  • | • Arterial Hypoxemia (low SaO₂) | (microvascular AV shunting) |
  • | • Anemia / Severe Hemorrhage | • Cyanide Poisoning / Met-Hb |
  • | • Hyperthermia, Shivering, Seizures| (cellular histotoxic poisoning) |
  • | • Malignant Hyperthermia | • Hypothermia (reduced VO₂) |
  • | • Thyroid Storm | • Wedged PAC (measures capillary) |
  • +------------------------------------+------------------------------------+

Loading diagram... Pulmonary Artery Catheter Chamber Progression and Pressure Waveforms